A Single-Arm, Open-Label, Phase 1 Study to Determine the Safety, Tolerability and Preliminary Efficacy of Obecabtagene Autoleucel in Patients with Severe, Refractory Systemic Lupus Erythematosus
AUTO1-SL1
Phase 1 other active
Quick answer
A Single-Arm, Open-Label, Phase 1 Study to Determine the Safety, Tolerability and Preliminary Efficacy of Obecabtagene Autoleucel in Patients with Severe, Refractory Systemic Lupus Erythematosus for Severe, Refractory Systemic Lupus Erythematosus is a Phase 1 program (other) at Autolus GmbH with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Autolus GmbH
- Indication
- Severe, Refractory Systemic Lupus Erythematosus
- Phase
- Phase 1
- Modality
- other
- Status
- active